[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Heparin Market Report 2018

March 2018 | 111 pages | ID: UE2213070A7QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Heparin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Heparin in these regions, from 2013 to 2025 (forecast).
United States Heparin market competition by top manufacturers/players, with Heparin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Hepalink
  • N.V.Organon?Aspen Pharmacare?
  • Pfizer
  • Opocrin
  • Sanofi-Aventis
  • Sandoz(Novartis)
  • Leo
  • King-friend Biochemical Pharmaceutical
  • Changshan Biochemical Pharmaceutical
  • Qianhong Biopharma
  • Dongcheng Biochemicals
  • Jiulong Biochemicals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • UFH
  • LMWH
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Thromboembolic Disease
  • Disseminated Intravascular Coagulation
  • Anticoagulation
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Heparin Market Report 2018

1 HEPARIN OVERVIEW

1.1 Product Overview and Scope of Heparin
1.2 Classification of Heparin by Product Category
  1.2.1 United States Heparin Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Heparin Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 UFH
  1.2.4 LMWH
  1.2.5 Others
1.3 United States Heparin Market by Application/End Users
  1.3.1 United States Heparin Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Thromboembolic Disease
  1.3.3 Disseminated Intravascular Coagulation
  1.3.4 Anticoagulation
  1.3.5 Other
1.4 United States Heparin Market by Region
  1.4.1 United States Heparin Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Heparin Status and Prospect (2013-2025)
  1.4.3 Southwest Heparin Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Heparin Status and Prospect (2013-2025)
  1.4.5 New England Heparin Status and Prospect (2013-2025)
  1.4.6 The South Heparin Status and Prospect (2013-2025)
  1.4.7 The Midwest Heparin Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Heparin (2013-2025)
  1.5.1 United States Heparin Sales and Growth Rate (2013-2025)
  1.5.2 United States Heparin Revenue and Growth Rate (2013-2025)

2 UNITED STATES HEPARIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Heparin Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Heparin Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Heparin Average Price by Players/Suppliers (2013-2018)
2.4 United States Heparin Market Competitive Situation and Trends
  2.4.1 United States Heparin Market Concentration Rate
  2.4.2 United States Heparin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Heparin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEPARIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Heparin Sales and Market Share by Region (2013-2018)
3.2 United States Heparin Revenue and Market Share by Region (2013-2018)
3.3 United States Heparin Price by Region (2013-2018)

4 UNITED STATES HEPARIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Heparin Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Heparin Revenue and Market Share by Type (2013-2018)
4.3 United States Heparin Price by Type (2013-2018)
4.4 United States Heparin Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HEPARIN SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Heparin Sales and Market Share by Application (2013-2018)
5.2 United States Heparin Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPARIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Hepalink
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Heparin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Hepalink Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 N.V.Organon?Aspen Pharmacare?
  6.2.2 Heparin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 N.V.Organon?Aspen Pharmacare? Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Heparin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Opocrin
  6.4.2 Heparin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi-Aventis
  6.5.2 Heparin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi-Aventis Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sandoz(Novartis)
  6.6.2 Heparin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sandoz(Novartis) Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Leo
  6.7.2 Heparin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Leo Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 King-friend Biochemical Pharmaceutical
  6.8.2 Heparin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Changshan Biochemical Pharmaceutical
  6.9.2 Heparin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Changshan Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Qianhong Biopharma
  6.10.2 Heparin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Qianhong Biopharma Heparin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Dongcheng Biochemicals
6.12 Jiulong Biochemicals

7 HEPARIN MANUFACTURING COST ANALYSIS

7.1 Heparin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Heparin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Heparin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Heparin Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPARIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Heparin Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Heparin Sales Volume Forecast by Type (2018-2025)
11.3 United States Heparin Sales Volume Forecast by Application (2018-2025)
11.4 United States Heparin Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Heparin
Figure United States Heparin Market Size (K Pcs) by Type (2013-2025)
Figure United States Heparin Sales Volume Market Share by Type (Product Category) in 2017
Figure UFH Product Picture
Figure LMWH Product Picture
Figure Others Product Picture
Figure United States Heparin Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Heparin by Application in 2017
Figure Thromboembolic Disease Examples
Table Key Downstream Customer in Thromboembolic Disease
Figure Disseminated Intravascular Coagulation Examples
Table Key Downstream Customer in Disseminated Intravascular Coagulation
Figure Anticoagulation Examples
Table Key Downstream Customer in Anticoagulation
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Heparin Market Size (Million USD) by Region (2013-2025)
Figure The West Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Heparin Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Heparin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Heparin Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Heparin Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Heparin Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Heparin Sales Share by Players/Suppliers
Figure 2017 United States Heparin Sales Share by Players/Suppliers
Figure United States Heparin Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Heparin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Heparin Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Heparin Revenue Share by Players/Suppliers
Figure 2017 United States Heparin Revenue Share by Players/Suppliers
Table United States Market Heparin Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Heparin Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Heparin Market Share of Top 3 Players/Suppliers
Figure United States Heparin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Heparin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Heparin Product Category
Table United States Heparin Sales (K Pcs) by Region (2013-2018)
Table United States Heparin Sales Share by Region (2013-2018)
Figure United States Heparin Sales Share by Region (2013-2018)
Figure United States Heparin Sales Market Share by Region in 2017
Table United States Heparin Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Heparin Revenue Share by Region (2013-2018)
Figure United States Heparin Revenue Market Share by Region (2013-2018)
Figure United States Heparin Revenue Market Share by Region in 2017
Table United States Heparin Price (USD/Pcs) by Region (2013-2018)
Table United States Heparin Sales (K Pcs) by Type (2013-2018)
Table United States Heparin Sales Share by Type (2013-2018)
Figure United States Heparin Sales Share by Type (2013-2018)
Figure United States Heparin Sales Market Share by Type in 2017
Table United States Heparin Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Heparin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Heparin by Type (2013-2018)
Figure Revenue Market Share of Heparin by Type in 2017
Table United States Heparin Price (USD/Pcs) by Types (2013-2018)
Figure United States Heparin Sales Growth Rate by Type (2013-2018)
Table United States Heparin Sales (K Pcs) by Application (2013-2018)
Table United States Heparin Sales Market Share by Application (2013-2018)
Figure United States Heparin Sales Market Share by Application (2013-2018)
Figure United States Heparin Sales Market Share by Application in 2017
Table United States Heparin Sales Growth Rate by Application (2013-2018)
Figure United States Heparin Sales Growth Rate by Application (2013-2018)
Table Hepalink Basic Information List
Table Hepalink Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hepalink Heparin Sales Growth Rate (2013-2018)
Figure Hepalink Heparin Sales Market Share in United States (2013-2018)
Figure Hepalink Heparin Revenue Market Share in United States (2013-2018)
Table N.V.Organon?Aspen Pharmacare? Basic Information List
Table N.V.Organon?Aspen Pharmacare? Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure N.V.Organon?Aspen Pharmacare? Heparin Sales Growth Rate (2013-2018)
Figure N.V.Organon?Aspen Pharmacare? Heparin Sales Market Share in United States (2013-2018)
Figure N.V.Organon?Aspen Pharmacare? Heparin Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Heparin Sales Growth Rate (2013-2018)
Figure Pfizer Heparin Sales Market Share in United States (2013-2018)
Figure Pfizer Heparin Revenue Market Share in United States (2013-2018)
Table Opocrin Basic Information List
Table Opocrin Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Opocrin Heparin Sales Growth Rate (2013-2018)
Figure Opocrin Heparin Sales Market Share in United States (2013-2018)
Figure Opocrin Heparin Revenue Market Share in United States (2013-2018)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi-Aventis Heparin Sales Growth Rate (2013-2018)
Figure Sanofi-Aventis Heparin Sales Market Share in United States (2013-2018)
Figure Sanofi-Aventis Heparin Revenue Market Share in United States (2013-2018)
Table Sandoz(Novartis) Basic Information List
Table Sandoz(Novartis) Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sandoz(Novartis) Heparin Sales Growth Rate (2013-2018)
Figure Sandoz(Novartis) Heparin Sales Market Share in United States (2013-2018)
Figure Sandoz(Novartis) Heparin Revenue Market Share in United States (2013-2018)
Table Leo Basic Information List
Table Leo Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Leo Heparin Sales Growth Rate (2013-2018)
Figure Leo Heparin Sales Market Share in United States (2013-2018)
Figure Leo Heparin Revenue Market Share in United States (2013-2018)
Table King-friend Biochemical Pharmaceutical Basic Information List
Table King-friend Biochemical Pharmaceutical Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure King-friend Biochemical Pharmaceutical Heparin Sales Growth Rate (2013-2018)
Figure King-friend Biochemical Pharmaceutical Heparin Sales Market Share in United States (2013-2018)
Figure King-friend Biochemical Pharmaceutical Heparin Revenue Market Share in United States (2013-2018)
Table Changshan Biochemical Pharmaceutical Basic Information List
Table Changshan Biochemical Pharmaceutical Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Changshan Biochemical Pharmaceutical Heparin Sales Growth Rate (2013-2018)
Figure Changshan Biochemical Pharmaceutical Heparin Sales Market Share in United States (2013-2018)
Figure Changshan Biochemical Pharmaceutical Heparin Revenue Market Share in United States (2013-2018)
Table Qianhong Biopharma Basic Information List
Table Qianhong Biopharma Heparin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Qianhong Biopharma Heparin Sales Growth Rate (2013-2018)
Figure Qianhong Biopharma Heparin Sales Market Share in United States (2013-2018)
Figure Qianhong Biopharma Heparin Revenue Market Share in United States (2013-2018)
Table Dongcheng Biochemicals Basic Information List
Table Jiulong Biochemicals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Heparin
Figure Manufacturing Process Analysis of Heparin
Figure Heparin Industrial Chain Analysis
Table Raw Materials Sources of Heparin Major Players/Suppliers in 2017
Table Major Buyers of Heparin
Table Distributors/Traders List
Figure United States Heparin Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Heparin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Heparin Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Heparin Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Heparin Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Heparin Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Heparin Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Heparin Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Heparin Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Heparin Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Heparin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Heparin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Heparin Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications